Back to Screener

Healthcare

Eli Lilly and Company(LLY)

Data coverage status ยท 6 need attention

Quote through 2026-08-05T13:30:00Z ยท Stale

Quote synced 2026-08-05T22:32:32.241646Z

Daily bars through 2026-08-03 ยท Stale

Daily bars synced 2026-08-04T22:41:42.599122Z

Fundamentals through 2025-12-31 ยท Stale

Fundamentals synced 2026-08-05T21:09:45.46753Z

Forecasts: Stale

Forecasts synced 2026-04-28T14:30:39.333549Z

Ownership through 2025-12-31 ยท Stale

Ownership synced 2026-08-05T21:09:45.46753Z

Short interest through 2025-12-31 ยท Stale

Short interest synced 2026-08-05T21:09:45.46753Z

News through 2026-08-03T21:08:39Z ยท Delayed

News synced 2026-08-03T22:32:21.818502Z

Company profile: Delayed

Company profile synced 2026-05-01T16:05:05.652154Z

Regular-session price

Offline

$1,169.86($1,123.00 after-hours, +0.50%)

+4.86% regular session

1Y Change

+45.73%

Window

Aug 5, 2025 โ†’ Aug 4, 2026

Market Cap
$915.33B
P/E
34.3
Trailing
52W Range
$623.78 - $1,249.45
Volume
5.50M
2.4x RVOL

Investment Snapshot

Valuation, growth, profitability, catalysts, and benchmark context.

Quote + TTM fundamentalsForecast

1D

+4.9%

1M

-7.0%

6M

+0.8%

YTD

+3.3%

1Y

+45.7%

Coverage: 250 bars ยท Aug 5, 2025 โ†’ Aug 4, 2026

Benchmark Edge

LLY vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

LLY is 22.90 pts ahead over the shared 1Y window.

LLY had 14.18 pts deeper max drawdown than SPY.

LLY beat SPY in 1 of 2 calendar years shown and trailed in 1.

LLY

+45.73%

Normalized return

SPY

+22.83%

S&P 500

Excess Return

+22.90 pts

Relative to SPY

LLY Max Drawdown

-23.31%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

LLYSPY

Calendar-Year Returns

Uses the longest available daily history for LLY and SPY.

YearLLYSPYExcessLeader
2026+3.32%+12.67%-9.35 ptsSPY
2025+40.97%+9.40%+31.57 ptsLLY

Earnings Reports

Next earnings reportSep 4, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q2
Apr 30, 26
โœ“
8.55
Est 6.79
+25.9%
โ€”
Est โ€”
โ€”
Apr 30
Q1
Feb 4, 26
โœ“
7.54
Est 6.91
+9.1%
โ€”
Est โ€”
โ€”
Feb 4
Q4
Oct 30, 25
โœ“
7.02
Est 5.89
+19.2%
โ€”
Est โ€”
โ€”
Oct 30
Q3
Sep 10, 25
โœ—
-0.31
Est -0.16
-93.8%
โ€”
Est โ€”
โ€”
Sep 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.